Ulcerative Colitis natural
and alternative treatment with diet, food, supplements, probiotics, prebiotics,
and herbs, home remedy therapy
November 10 2018 by
Ray Sahelian, M.D.
Ulcerative colitis is a severe inflammatory bowel disease of the colon that produces bloody diarrhea. With Crohn's disease the inflammation typically involves the small intestine, but it can affect any part of the gastrointestinal tract, whereas with ulcerative colitis, the disease is usually confined to the colon and rectum.
The cause of this disease is still not well understood. Risk factors include a history of recent infection with Salmonella or Campylobacter, living in Western industrialized nations, and a family history of the disease. The incidence peaks in early adulthood, but patients can develop the disorder from early childhood through adulthood.
Lifestyle factors
Symptoms of this condition may be reduced by engaging in physical activity,
eating a healthy diet,
keeping a normal weight, and by not smoking.
Not getting the right amount of sleep raises the risk of ulcerative colitis, American Gastroenterological Association, news release, Oct. 21, 2014.
Diet, food, does what we eat have
an influence?
People who eat lots of red meat, concentrated milk fats, cook with certain types
of oil, and use some
kinds of polyunsaturated fatty acid (PUFA)-heavy margarines increase their risk
of a painful inflammatory bowel disease. These foods are high in linoleic acid
and people who are the heaviest consumers of this omega-6 PUFA are more than
twice as likely to develop ulcerative colitis as those who consume the least.
Dr. Andrew Hart of the University of East Anglia in Norwich, UK, found that
eating more eicosapentaenoic acid, an omega-3 fatty acid found in fish and fish
oils, is associated with a lower risk of the disease. While a Western-style,
red-meat-heavy diet is high in this fatty acid and low in omega-3s, a more
Mediterranean style eating pattern -- with plenty of fruits and vegetables,
fish, and nut oils -- would be low in linoleic acid and high in omega-3. Dr.
Andrew Hart thinks that if omega-3s do help prevent ulcerative colitis, eating a
couple of servings of fish a week would probably be of benefit. Gut, December
2009.
Salmon diet in patients with active ulcerative colitis
reduced the simple clinical colitis activity index and increased the
anti-inflammatory fatty acid index - a pilot study.
Scand J Clin Lab Invest. 2010.
Department of Internal Medicine, Stavanger University Hospital, Stavanger,
Norway.
Data concerning the anti-inflammatory effect of dietary n-3 polyunsaturated
fatty acids (PUFAs) in patients with ulcerative colitis (UC) are inconsistent.
Salmon fillet contains n-3 PUFAs and bioactive peptides that may improve its
effects compared to fish oil alone. We assessed the efficacy of a salmon-rich
diet in patients with mild ulcerative colitis. Methods. An 8-week intervention
pilot study was designed to assess the effects of 600 grams Atlantic salmon
consumption weekly in 12 UC patients. Simple clinical colitis activity index (SCCAI),
a dietary questionnaire, sigmoidoscopy, selected serum inflammatory markers,
fecal calprotectin, and plasma and rectal biopsy fatty acid profiles were
assessed before and after intervention. The levels of C20:4n-6 arachidonic acid
in biopsies after dietary intervention were correlated with histology and
endoscopy scores. The concentrations of n-3 PUFAs, C20:5n-3 eicosapentaenoic
acid, C22:6n-3 docosahexaenoic acid, and the n-3/n-6 ratio increased in plasma
and rectal biopsies. The anti-inflammatory fatty acid index increased both in
biopsies and plasma accompanied with a significantly reduced SCCAI. Based on
evidence of SCCAI and anti-inflammatory fatty acid index and a tendency of
decreased levels of CRP and homocysteine, intake of Atlantic salmon may have
beneficial effects on disease activity in patients with mild ulcerative colitis.
Increasing fiber intake appears to be of benefit.
Nutritional treatment
to ulcerative colitis symptoms
Doctors are still trying to figure out the best option for a natural
approach to the treatment of ulcerative colitis. Little by little more data is
coming in, however, as of 2011, I am only aware of a few studies with
natural supplements that have shown some promise. I am not sure if the
supplements discussed below will help a particular person with ulcerative colitis get better. Discuss these
findings with your doctor and see what he or she says.
Agaricus blazei mushroom
Effect of an extract based on the medicinal mushroom Agaricus blazei Murill on
expression of cytokines and calprotectin in patients with ulcerative colitis and
Crohn's disease.
Scand J Immunol. 2011. Department of Gastroenterological Surgery, Oslo
University Hospital, Ullevål, Oslo, Norway.
An immunomodulatory extract (AndoSan) based on the medicinal mushroom
Agaricus blazei Murill
has shown to reduce blood cytokine levels in healthy volunteers after 12 days'
ingestion, pointing to an anti-inflammatory effect. The aim was to study whether
AndoSan™ had similar effects on cytokines in patients with ulcerative colitis (UC)
and Crohn's disease (CD). Ingestion of an Agaricus blazei-based medicinal
mushroom by patients with IBD resulted in interesting anti-inflammatory effects
as demonstrated by declined levels of pathogenic cytokines in blood and
calprotectin in faeces.
PLoS One. 2016. Effect of a Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSan, on Symptoms, Fatigue and Quality of Life in Patients with Ulcerative Colitis in a Randomized Single-Blinded Placebo Controlled Study. 50 patients with symptomatic ulcerative colitis were block-randomized and blinded for oral daily intake of AndoSan or placebo for the 21 days' experimental period.Beneficiary effects on symptoms, fatigue from AndoSan consumption were demonstrated in this per-protocol study, supporting its use as a supplement to conventional medication for patients with mild to moderate symptoms from ulcerative colitis.
Aloe Vera use
Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for
active ulcerative colitis.
Aliment Pharmacol Ther. 2004 Apr. Centre for
Gastroenterology, Institute of Cellular and Molecular Science, Barts and The
London, Queen Mary School of Medicine and Dentistry, London, UK.
The herbal preparation,
aloe vera, has been claimed to have anti-inflammatory
effects and, despite a lack of evidence of its therapeutic efficacy, is widely
used by patients with inflammatory bowel disease. We performed a double-blind,
randomized, placebo-controlled trial of the efficacy and safety of aloe vera gel
for the treatment of mildly to moderately active ulcerative colitis. Forty-four
evaluable hospital out-patients were randomly given oral aloe vera gel or
placebo, 100 mL twice daily for 4 weeks, in a 2 : 1 ratio. Clinical remission,
improvement and response occurred in nine (30%), 11 (37%) and 14 (47%),
respectively, of 30 patients given aloe vera, compared with one (7%), one (7%) and two
(14%), respectively, of 14 patients taking
placebo. The Simple Clinical Colitis Activity Index and histological scores
decreased significantly during treatment with aloe vera, but not with placebo.
Sigmoidoscopic scores and laboratory variables showed no significant differences
between aloe vera and placebo. Adverse events were minor and similar in both
groups of patients. Oral aloe vera taken for 4 weeks produced a
clinical response more often than placebo; it also reduced the histological
disease activity and appeared to be safe.
Anti-inflammatory effects of aloe vera gel
in human colorectal mucosa in vitro.
Aliment Pharmacol Ther. 2004 Mar. Centre for Adult and Paediatric Gastroenterology, Institute of Cellular and Molecular Science, Barts
and the London, Queen Mary School of Medicine and Dentistry, London, UK.
Oral aloe vera gel is widely used by patients with inflammatory bowel disease
and is under therapeutic evaluation for this condition. The anti-inflammatory
actions of aloe vera gel in vitro provide support for the proposal that it may
have a therapeutic effect in inflammatory bowel disease.
I would appreciate your view on the use of AMP (
aloe mucilagenous polysaccharides ) for the treatment of ulcerative colitis.
A short term study with aloe vera for a month showed some
improvement, but longer studies are not available to determine how effective
aloe is for this condition.
Curcumin is an extract from turmeric
Curcumin in Combination With Mesalamine Induces Remission in Patients With
Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial. We
investigated curcumin in inducing remission in patients with active
mild-to-moderate UC. We performed a multicenter randomized, placebo-controlled,
double-blind study of 50 mesalamine-treated patients with active
mild-to-moderate UC who did not respond to an additional 2 weeks of the maximum
dose of mesalamine oral and topical therapy. Patients were randomly assigned to
groups who were given curcumin capsules 3 g/day or an identical placebo for 1
month, with continued mesalamine. Addition of curcumin to mesalamine therapy was
superior to the combination of placebo and mesalamine in inducing clinical and
endoscopic remission in patients with mild-to-moderate active UC, producing no
apparent adverse effects. Curcumin may be a safe and promising agent for
treatment of UC.
Curcumin maintenance therapy for
ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled
trial.
Clin Gastroenterol Hepatol. 2006. Department of Endoscopic and Photodynamic Medicine, Hamamatsu
University School of Medicine, Hamamatsu, Japan; Center for Gastroenterology,
Hamamatsu South Hospital, Hamamatsu, Japan.
The aim in this trial was to assess the efficacy of curcumin as maintenance
therapy in patients with quiescent ulcerative colitis. Eighty-nine patients with
quiescent ulcerative colitis were recruited for this randomized, double-blind, multicenter trial of curcumin in the prevention of relapse. Forty-five patients
received curcumin, 1g after breakfast and 1g after the evening meal, plus
sulfasalazine or mesalamine, and 44 patients received
placebo plus SZ or
mesalamine for 6 months. Of 43 patients who received curcumin, 2 relapsed during
6 months of therapy (4%), whereas 8 of 39 patients (20%) in the placebo group
relapsed. Recurrence rates evaluated on the basis of intention to treat showed
significant difference between curcumin and placebo. A 6-month follow-up was
done during which patients in both groups were on sulfasalazine or mesalamine. Eight
additional patients in the curcumin group and 6 patients in the placebo group
relapsed. Curcumin seems to be a promising and safe medication for
maintaining remission in patients with quiescent ulcerative colitis. Further
studies on curcumin should strengthen our findings.
Modulation of neutrophil motility by
curcumin: Implications for inflammatory bowel disease.
Inflamm Bowel Dis. 2010. Larmonier CB, Midura-Kiela MT, Ramalingam R,
Laubitz D, Janikashvili N, Larmonier N, Ghishan FK. Department of
Pediatrics, Steele Children's Research Center, Tucson, Arizona.
Curcumin attenuated lipopolysaccharide (LPS)-stimulated expression and secretion
of macrophage inflammatory protein (MIP)-2, interleukin (IL)-1β, keratinocyte
chemoattractant (KC), and MIP-1α in colonic epithelial cells (CECs) and in
macrophages. Curcumin significantly inhibited PMN chemotaxis against MIP-2, KC,
or against conditioned media from LPS-treated macrophages or CEC, a well as the
IL-8-mediated chemotaxis of human neutrophils. At nontoxic concentrations,
curcumin inhibited random neutrophil migration, suggesting a direct effect on
neutrophil chemokinesis. Curcumin-mediated inhibition of PMN motility could be
attributed to a downregulation of PI3K activity, AKT phosphorylation, and F-actin
polymerization at the leading edge. Our results indicate that curcumin
interferes with colonic inflammation partly through inhibition of the chemokine
expression and through direct inhibition of neutrophil chemotaxis and
chemokinesis.
Immunopharmacol Immunotoxicol. 2018. Curcumin as a therapeutic agent for blocking NF-κB activation in ulcerative colitis. Curcumin is a nontoxic, inexpensive, and easily available natural polyphenol and can be used as a potential and safe herb in the management of patients with remission and mild-to-moderate UC.
N-acetyl-L-cysteine
is a potent antioxidant
N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative
colitis: randomized, placebo-controlled pilot study.
World J Gastroenterol. 2008. Guijarro LG, Mate J, Gisbert JP, Perez-Calle
JL, Marin-Jimenez I, Arriaza E, Delgado M, Castillejo MS, Prieto-Merino
D, Gonzalez Lara V, Pena AS. Unidad de Toxicologia Molecular Hepatica,
Department de Bioquimica & Biologia Molecular, Universidad de Alcala, E-28871,
Alcala de Henares, Spain.
To evaluate the effectiveness and safety of oral N-acetyl-L-cysteine (NAC)
co-administration with mesalamine in ulcerative colitis (UC) patients. Thirty
seven patients with mild to moderate ulcerative colitis were randomized to
receive a four-wk course of oral mesalamine (2.4 g/d) plus N-acetyl-L-cysteine
(0.8 g/d) (group A) or mesalamine plus placebo (group B). Analysis per-protocol
criteria showed clinical remission rates of 63% and 50% after 4 wk treatment
with mesalamine plus N-acetyl-L-cysteine (group A) and mesalamine plus placebo
(group B) respectively. Clinical responses were 66% (group A) vs 44% (group B)
after 4 wk of treatment. Clinical improvement in group A correlated with a
decrease of IL-8 and MCP-1. Rates of adverse events did not differ significantly
between both groups. In group A (oral NAC combined with mesalamine)
contrarily to group B (mesalamine alone), the clinical improvement correlates
with a decrease of chemokines such as MCP-1 and IL-8. NAC addition not produced
any side effects.
Phophatidylcholine is
a phospholipid, also known as lecithin
Low levels of
phosphatidylcholine in the mucous tissues of the colon may
contribute to the development of ulcerative colitis. Dr. Wolfgang Stremmel, from
University Hospital Heidelberg in Germany, and colleagues randomly assigned 60
patients to receive phosphatidylcholine or a placebo four times daily for 12
weeks. The preparations were encapsulated so that they would not be released
until they reached the intestines. Fifteen of 30 patients in the
phosphatidylcholine group were able to stop using steroids while maintaining a
low clinical disease activity index or improving the index. By contrast, just 3
of 30 patients in the placebo group achieved this outcome. Mild bloating was the
most common side effect seen with phosphatidylcholine use. Annals of Internal
Medicine, November 6, 2007.
Probiotics are known as
friendly bacteria
Probiotics, living, non pathogenic micro organisms with a beneficial
effect on the host, and
prebiotics, oligosaccharides promoting the growth of the beneficial
microflora, have been studied to this effect.
Taking a mixture of
several
probiotic bacteria reduces symptoms in patients with ulcerative colitis that doesn't
respond to conventional medications. The probiotic mixture contained four strains of Lactobacillus, three strains of Bifidobacterium
and one strain of Streptococcus salivarius -- all well-known species of
good bacteria. Researchers from the University of Alberta in Edmonton,
Canada enrolled 34 patients with
active ulcerative colitis who were treated with the probiotic mixture twice daily for 6
weeks. A variety of standard treatments had been tried on the patients
first, with no help. Remission occurred in 53 percent of the
patients and an additional 24 percent experienced some degree of
improvement in symptoms. A few patients experienced no improvement or
worsening of their symptoms. The only apparent side effect from the
probiotic mixture was increased bloating. Testing of sampled colonic tissue provided
direct evidence that the probiotic bacteria had, in fact, reached the
diseased sites of the colon. American Journal
of Gastroenterology, 2005.
Scand J Gastroenterol. 2005. Outcome of four weeks' intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis. Pouchitis is a common and troublesome condition in patients operated on with ileal-pouch-anal-anastomosis (IPAA). A disturbed microecology in the pouch has been suggested as one possible explanation. In a previous double-blind, randomized, controlled study we demonstrated clinical improvement of symptoms in patients with ulcerative colitis (UC) operated on with IPAA, during intervention with live probiotic microbes Lactobacilli and Bifidobacteriae. Five hundred millilitres of a fermented milk product (Cultura) containing live lactobacilli (La-5) and bifidobacteriae (Bb-12) was given daily for 4 weeks to 51 UC patients and 10 patients with FAP, operated on with IPAA, and six UC patients operated on for IRA. Results of this extended study, showing an effect of probiotics on symptoms and endoscopic inflammation in UC patients operated on with IPAA confirm our previously reported effect of probiotics on clinical symptoms and endoscopic score in a smaller, double-blind, randomized, controlled study. The significantly higher response to probiotics in families with increased risk of IBD will have to be repeated in future studies.
Effect of probiotics on pro-inflammatory
cytokines and NF-kappaB activation in ulcerative colitis.
World J Gastroenterol. 2010. Hegazy SK, El-Bedewy MM. Department of
Clinical Pharmacy, Faculty of Pharmacy, Tanta University, Egypt.
Thirty patients with mild to moderate UC were randomly classified into two
groups: sulfasalazine group, who received sulfasalazine 2400 mg/d; and probiotic
group, who received sulfasalazine 2400 mg/d with probiotic. The patients were
investigated before and after 8 wk of treatment with probiotic (Lactobacillus
delbruekii and Lactobacillus fermentum). Oral supplementation with probiotics
could be helpful in maintaining remission and preventing relapse of UC.
Zhonghua Wei Chang Wai Ke Za Zhi. 2013. Efficacy of probiotics on ulcerative colitis and its mechanism.
Synbiotic therapy for ulcerative
colitis
A randomized controlled trial on the efficacy of synbiotic versus probiotic or
prebiotic treatment to improve the quality of life in patients with ulcerative
colitis.
Nutrition. 2009 Feb 6. Fujimori S, Gudis K, Mitsui K, Seo T, Yonezawa M,
Tanaka S, Tatsuguchi A, Sakamoto C. Department of Internal Medicine, Division of
Gastroenterology, Nippon Medical School, Tokyo, Japan.
Studies suggest that synbiotic therapy could prove more effective in the
treatment of ulcerative colitis than therapies limited to probiotics or
prebiotics. This study compared the effect of each of these therapies in the
treatment of ulcerative colitis. One hundred twenty outpatients with ulcerative
colitis were randomly sorted into three groups of 40 patients each for probiotic,
prebiotic, or synbiotic therapy. The probiotic group ingested one daily capsule
consisting of Bifidobacterium longum 2 x 10(9) colony-forming units and the
prebiotic group ingested daily 8 gram doses of psyllium. The synbiotic group
underwent both treatments. Patients with ulcerative colitis on synbiotic therapy
experienced greater quality-of-life changes than patients on probiotic or
prebiotic treatment. These data suggest that synbiotic therapy may have a
synergistic effect in the treatment of ulcerative colitis.
Symptoms and diagnosis
Ulcerative colitis often presents with abdominal pain, diarrhea, and blood
in the stools. It is important to exclude infectious etiologies. Anemia and an
elevated erythrocyte sedimentation rate or C-reactive protein level may suggest
inflammatory bowel disease, but the absence of laboratory abnormalities does not
rule out ulcerative colitis. The diagnosis is suspected clinically and confirmed
through endoscopic biopsy.
Medical treatment
First-line treatment is therapy with 5-aminosalicylic acid. Corticosteroids
may be added if 5-aminosalicylic acid therapy is ineffective. Infliximab can be
added to induce and sustain remission. Patients with severe or nonresponsive
ulcerative colitis should be hospitalized, and intravenous corticosteroids
should be given. If medical management has been ineffective, surgical
intervention is indicated for severe disease. Patients with ulcerative colitis
have an increased risk of colon cancer and should have periodic colonoscopy
beginning eight to 10 years after diagnosis.
Some causes, more will be added
Adults who were physically or sexually abused as children may be at
increased risk for the inflammatory bowel disease ulcerative colitis.
Perm J. 2016. Onset of Ulcerative Colitis after Helicobacter pylori Eradication Therapy: A Case Report.
Natural and
alternative Ulcerative Colitis treatment questions
I was recently diagnosed with ulcerative
colitis and am trying both prescription and natural ways to get into remission.
I was reading about the studies done of germinated barley foodstuff and how it
helps those with ulcerative colitis. I can't find any supplements however that
are called germinated barley foodstuff . According to the studies the barley
must be germinated to be effective for ulcerative colitis. Can you help me
locate a supplement (prebiotic) germinated barley foodstuff.
We can't find a product yet that is called germinated barley
foodstuff but we will keep our eyes open.
This is briefly mentioned on your ulcerative colitis page. Just FYI, germinate barley foodstuffs are widely prescribed for mild cases of ulcerative colitis in Japan, and I believe the manufacturer is a Japanese beer manufacturer - can't remember if its Kirin or Asahi. It might be hard to get in the US but is easy to find in Japan.
Would cat's claw or boswellia be worth researching for effects on
ulcerative colitis?
Both cat's claw and boswellia have anti-inflammatory properties
but we have not yet seen much human research on these herbs for the
natural treatment of ulcerative colitis.
My husband, 74, has chronic ulcerative colitis
for years, however, the last year and half, his condition is getting worse.
According to his primary doctor, there is no lining (or very thin) in his colon,
and needs to have his whole colon removed. He has diarrhea 30 times a day which
also causes hemorrhoid. We have been referred to take extra flora, which seems
little help. Shall he continue to take the medication that doctor has prescribed
to him for life, sulfasalazine, which is an antibiotic, and this medication will
kill whatever bacteria in the intestine. Would this contradict to taking flora
and also the sulfasalazine? Please help and suggest a nutritional regiment.
Thank you as we are desperate for natural healing, rather than to have surgery
which has no guarantee. Can you suggest any nutritional supplements for
ulcerative colitis?
I can't give specific suggestions, but I don't think taking prebiotics or probiotics interferes with the medication. Perhaps some of the
suggestions on this page will be of benefit that you can discuss with your
doctor.